Search
Guanosine tetraphosphate
go.drugbank.com/drugs/DB04022ExperimentalGuanosine tetraphosphate is a guanine nucleotide containing four phosphate groups. … This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis.
Methoxyphenamine
go.drugbank.com/drugs/DB13624ApprovedCategories: Adrenergics for Systemic Use, Drugs for Obstructive Airway DiseasesTriazavirin
go.drugbank.com/drugs/DB15622Investigational[L12087] Given the similarities between SARS-CoV-2 and H5N1, health officials are investigating Triazavirin as an option to combat SARS-CoV-2, the coronavirus responsible for COVID-19.[A191625]
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseTemocillin
go.drugbank.com/drugs/DB12343ApprovedInvestigationalWithdrawnTemocillin has been investigated in Infection, Liver Dysfunction, and Urinary Tract Infection.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseBendroflumethiazide
go.drugbank.com/drugs/DB00436ApprovedInvestigationalA thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 3...
Categories: Antihypertensive Agents Indicated for HypertensionINO-4800
go.drugbank.com/drugs/DB15693InvestigationalINO-4800 is a DNA vaccine containing the full sequence for the SARS-CoV-2 Spike (S) protein in development for immunization against COVID-19. … [A214475] A Phase 1 clinical trial for INO-4800 in the U.S. (NCT04336410) was started on April 3, 2020, with an expected completion date of July 2021.
Categories: Experimental Unapproved Treatments for COVID-19Suzetrigine
go.drugbank.com/drugs/DB18927ApprovedInvestigationalblocker with analgesic properties[A264948] Na<sub>V</sub>1.8 is abundantly expressed in peripheral sensory nerves to play a role in pain signal transmission, making it a desirable therapeutic target for
Vanoxerine
go.drugbank.com/drugs/DB03701InvestigationalIt was synthesized in the late 1970s and developed as a potential treatment for depression. … [A248555] Vanoxerine is an investigational drug and has not been approved for therapeutic use.
Sulindac
go.drugbank.com/drugs/DB00605ApprovedInvestigationalThere is evidence from some studies that sulindac may be associated with fewer gastrointestinal side effects than other NSAIDs, except for the cyclooxygenase-2 (COX-2) inhibitor drug class. … Like other NSAIDs, it may be used in the treatment of acute or chronic inflammatory conditions.
Nicorandil
go.drugbank.com/drugs/DB09220ApprovedInvestigationalWithdrawnIt is often used for patients with angina who remain symptomatic despite optimal treatment with other antianginal drugs [T28].
International brands: Av-Cor, K-Cor